These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35830029)
1. ASCITIC AND SERUM LEVELS OF TUMOR BIOMARKERS (CA 72-4, CA 19-9, CEA AND CA 125) IN DISCRIMINATION OF CAUSE OF ASCITES: A PROSPECTIVE STUDY. Jain T; Ram S; Kumar H; Saroch A; Sharma V; Singh H Arq Gastroenterol; 2022; 59(2):198-203. PubMed ID: 35830029 [TBL] [Abstract][Full Text] [Related]
2. Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis. Kang SJ; Kim JW; Baek JH; Kim SH; Kim BG; Lee KL; Jeong JB; Jung YJ; Kim JS; Jung HC; Song IS World J Gastroenterol; 2012 Jun; 18(22):2837-43. PubMed ID: 22719194 [TBL] [Abstract][Full Text] [Related]
3. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites. Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823 [TBL] [Abstract][Full Text] [Related]
4. Utility of ascitic tumor markers and adenosine deaminase for differential diagnosis of tuberculous peritonitis and peritoneal carcinomatosis. Du L; Wei X; Xiao Z; Wang H; Song Y BMC Gastroenterol; 2022 Sep; 22(1):423. PubMed ID: 36115972 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Carcinoembryonic Antigen in Ascites for Colorectal Cancer with Peritoneal Carcinomatosis. Song SE; Choi P; Kim JH; Jung K; Kim SE; Moon W; Park MI; Park SJ Korean J Gastroenterol; 2018 Jun; 71(6):332-337. PubMed ID: 29943560 [TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites. Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362 [TBL] [Abstract][Full Text] [Related]
7. [Carcinoembryonic antigen (CEA) in ascites]. Coenen C; Schmidt G; Wegener M; Wedmann B; Bauer KH; Ricken D Fortschr Med; 1991 Apr; 109(13):280-2. PubMed ID: 2066045 [TBL] [Abstract][Full Text] [Related]
8. Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis. Bandyopadhyay R; Bandyopadhyay SK; Ghosal J; Kumar U; Dutta A J Indian Med Assoc; 2006 Apr; 104(4):174, 176-7, 185. PubMed ID: 16910322 [TBL] [Abstract][Full Text] [Related]
9. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis. Khan FY Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102 [TBL] [Abstract][Full Text] [Related]
10. Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study. Kim BC; Bae JH; Park SM; Won DY; Lee IK Int J Colorectal Dis; 2020 Jan; 35(1):147-155. PubMed ID: 31802190 [TBL] [Abstract][Full Text] [Related]
11. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology. Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585 [TBL] [Abstract][Full Text] [Related]
12. The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites. Jung M; Jeung HC; Lee SS; Park JY; Hong S; Lee SH; Noh SH; Chung HC; Rha SY J Cancer Res Clin Oncol; 2010 Apr; 136(4):517-26. PubMed ID: 19774395 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites. Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274 [TBL] [Abstract][Full Text] [Related]
14. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis. Catarino RM; Lopes JD; Forones NM; Parise ER Braz J Med Biol Res; 2005 Feb; 38(2):271-6. PubMed ID: 15785839 [TBL] [Abstract][Full Text] [Related]
15. Value of carcinoembryonic antigen (CEA) and cholesterol assays of ascitic fluid in cases of inconclusive cytology. Gulyás M; Kaposi AD; Elek G; Szollár LG; Hjerpe A J Clin Pathol; 2001 Nov; 54(11):831-5. PubMed ID: 11684715 [TBL] [Abstract][Full Text] [Related]
16. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt? Tuzun Y; Celik Y; Bayan K; Yilmaz S; Dursun M; Canoruc F J Int Med Res; 2009; 37(1):79-86. PubMed ID: 19215676 [TBL] [Abstract][Full Text] [Related]
17. Malignancy-related ascites and ascitic fluid "humoral tests of malignancy". Runyon BA J Clin Gastroenterol; 1994 Mar; 18(2):94-8. PubMed ID: 8189030 [TBL] [Abstract][Full Text] [Related]
18. Role of laparoscopic surgery in the etiologic diagnosis of exsudative ascites: a prospective study of 90 cases. Bedioui H; Ksantini R; Nouira K; Mekni A; Daghfous A; Chebbi F; Rebai W; Fteriche F; Jouini M; Kacem M; Ben Mami N; Filali A; Bensafta Z Gastroenterol Clin Biol; 2007 Dec; 31(12):1146-9. PubMed ID: 18176376 [TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen gradients between plasma and malignant ascites: use in detecting peritoneal and liver metastases. Loewenstein MS; Rittgers RA; Kupchik HZ; Zamcheck N J Natl Cancer Inst; 1981 May; 66(5):803-6. PubMed ID: 6939926 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of malignant versus tuberculous ascites using tumor markers and globulin ratios in serum and ascites: A Fisher discriminant model. Yu T; Shu L; Chen Y; Zhu Y; Lu N; Lai Y; Huang T; Shu X Arab J Gastroenterol; 2021 Jun; 22(2):93-98. PubMed ID: 34090828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]